Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Village Super Market
VLGEA
$627M
| $12.8M | 0.02% |
562,084
-1,200
| -0.2% | -$26.1K |
|
902
TIM SA
TIMB
$8.69B
| $12.8M | 0.02% |
834,286
+110,500
| +15% | +$1.56M |
|
903
Academy Sports + Outdoors
ASO
$3.05B
| $12.7M | 0.02% |
235,200
-312,600
| -57% | -$18M |
|
904
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $12.7M | 0.02% |
245,100
+27,800
| +13% | +$1.24M |
|
905
IPG Photonics
IPGP
$3.71B
| $12.7M | 0.02% |
93,200
+33,000
| +55% | +$3.89M |
|
|
APLS
906
DELISTED
Apellis Pharmaceuticals
APLS
| $12.6M | 0.02% |
+138,513
| New | +$12M |
|
|
LUCK
907
Lucky Strike Entertainment
LUCK
$937M
| $12.6M | 0.02% |
1,082,541
+179,341
| +20% | +$2.39M |
|
908
Univest Financial
UVSP
$1.18B
| $12.6M | 0.02% |
694,469
+18,380
| +3% | +$360K |
|
909
Freedom Holding
FRHC
$9.65B
| $12.6M | 0.02% |
155,319
+4,419
| +3% | +$347K |
|
910
Lennox International
LII
$14.5B
| $12.5M | 0.02% |
38,400
-122,400
| -76% | -$34.6M |
|
|
LKFT
911
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $12.5M | 0.02% |
307,900
-50,500
| -14% | -$2.06M |
|
912
Chegg
CHGG
$88.9M
| $12.5M | 0.02% |
1,406,700
+932,300
| +197% | +$11.3M |
|
913
ManpowerGroup
MAN
$2.61B
| $12.5M | 0.02% |
157,052
-20,900
| -12% | -$1.58M |
|
914
LegalZoom.com
LZ
$930M
| $12.5M | 0.02% |
1,030,942
+386,800
| +60% | +$4.09M |
|
915
Avista
AVA
$3.23B
| $12.4M | 0.02% |
316,545
-20,877
| -6% | -$885K |
|
916
Landstar System
LSTR
$6.31B
| $12.4M | 0.02% |
64,540
-6,300
| -9% | -$1.14M |
|
917
Evolution Petroleum
EPM
$134M
| $12.4M | 0.02% |
1,539,384
-224,813
| -13% | -$1.66M |
|
|
AIRC
918
DELISTED
Apartment Income REIT Corp.
AIRC
| $12.4M | 0.02% |
344,200
-316,300
| -48% | -$11.3M |
|
919
Great Southern Bancorp
GSBC
$877M
| $12.4M | 0.02% |
244,200
-1,900
| -0.8% | -$97.1K |
|
920
Tanger
SKT
$4.42B
| $12.4M | 0.02% |
560,526
+291,800
| +109% | +$5.85M |
|
921
Intapp
INTA
$3.05B
| $12.3M | 0.02% |
292,800
+210,700
| +257% | +$9.08M |
|
922
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.2B
| $12.3M | 0.02% |
823,784
-404,702
| -33% | -$4.91M |
|
923
Toyota
TM
$223B
| $12.2M | 0.02% |
+76,200
| New | +$11M |
|
|
CMRC
924
Commerce.com Inc Series 1
CMRC
$179M
| $12.2M | 0.02% |
1,229,500
-251,740
| -17% | -$2.1M |
|
925
Iovance Biotherapeutics
IOVA
$3.05B
| $12.2M | 0.02% |
1,732,700
-142,800
| -8% | -$1.02M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.